KADCYLA 160
Powder for concentrate for solution for infusion
registration number
49/32.16/0198
What KADCYLA 160 contains
trastuzumab emtansine.
other ingredients
Polysorbate 20, Sodium hydroxide, Succinic acid, Sucrose.
Therapeutic classification
L01XC14.